Autism 2025: Rising prevalence, real impact, enterprise role

Autism Spectrum Disorder is no longer a marginal public health issue. It's a global phenomenon with rising prevalence, steep economic costs and profound workforce implications, both a societal responsibility and a commercial opportunity for enterprises.

Prevalence trends

Globally, WHO estimates about 1 in 100 children are autistic; in the US, CDC data shows prevalence rose from 1 in 44 (2018) to 1 in 31 (2022), with boys over three times more likely to be diagnosed. Prevalence has increased over 300% since 2000, driven by broader diagnostic criteria and awareness. In India, surveys estimate 1-1.5% of children are autistic (roughly 1 in 68), equating to ~18 million people, with wide regional variation (Goa 0.4% vs Haryana 1.8%), underscoring under-diagnosis and awareness gaps.

Policy and infrastructure

The Rights of Persons with Disabilities Act 2016 recognizes ASD and mandates 4% reservation in government jobs and higher education. Insurance like Niramaya and Star Special Care provide partial therapy coverage, but out-of-pocket spending remains high. Under Samagra Shiksha, Block Resource Centres provide therapies and teacher training, while EdTech (Avaz AAC, WonderTree AR) enhances inclusive learning. India has fewer than 10,000 psychiatrists (mostly urban), so para-professionals and digital health platforms will be critical to scale.

Health impact and economic costs

Autism rarely occurs in isolation: GI problems (1 in 5 children), epilepsy, feeding issues (70%), ADHD (35%), and anxiety/depression (up to 26% of adults), demanding integrated care. The US lifetime cost rose from $268B (2015) toward $461B (2025) and could reach $1 trillion. ABA therapy at ~$120/hour means $62,400/year for ten hours weekly; autistic children cost families an extra $17,000-21,000/year.

Inclusion delivers ROI

Neurodiverse unemployment runs 30-40% (3x physical disability), yet disability-inclusive companies achieve 1.6x revenue, 2.6x net income and 2x profit (Accenture). Leading programs: SAP's "Autism at Work" (a dozen-plus countries including India), EY's Neuro-Diverse Centres of Excellence (23+ cities), Accenture's internships and neurodiverse insurance, Wells Fargo's "train-intern-hire" (320+ hires, 97% retention), and Specialisterne (20,000+ placements globally, 94% retention).

Monetization pathways

Therapy services (scalable telehealth and centers), digital health (AI screening like CogniAble, VR/AR tools), assistive technology (AAC devices), education and training platforms, inclusive-hiring consulting, and biotech/precision medicine (gene therapy trials for monogenic autism like Rett and Fragile X).